Cargando…
The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus
Biofilms are responsible for persistent or recurring microbial infections. Polymicrobial biofilms are prevalent in environmental and medical niches. Dual-species biofilms formed by Gram-negative uropathogenic Escherichia coli (UPEC) and Gram-positive Staphylococcus aureus are commonly found in urina...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301033/ https://www.ncbi.nlm.nih.gov/pubmed/37376127 http://dx.doi.org/10.3390/pharmaceutics15061679 |
_version_ | 1785064716752650240 |
---|---|
author | Park, Inji Jailani, Afreen Lee, Jin-Hyung Ahmed, Bilal Lee, Jintae |
author_facet | Park, Inji Jailani, Afreen Lee, Jin-Hyung Ahmed, Bilal Lee, Jintae |
author_sort | Park, Inji |
collection | PubMed |
description | Biofilms are responsible for persistent or recurring microbial infections. Polymicrobial biofilms are prevalent in environmental and medical niches. Dual-species biofilms formed by Gram-negative uropathogenic Escherichia coli (UPEC) and Gram-positive Staphylococcus aureus are commonly found in urinary tract infection sites. Metal oxide nanoparticles (NPs) are widely studied for their antimicrobial and antibiofilm properties. We hypothesized that antimony-doped tin (IV) oxide (ATO) NPs, which contain a combination of antimony (Sb) and tin (Sn) oxides, are good antimicrobial candidates due to their large surface area. Thus, we investigated the antibiofilm and antivirulence properties of ATO NPs against single- and dual-species biofilms formed by UPEC and S. aureus. ATO NPs at 1 mg/mL significantly inhibited biofilm formation by UPEC, S. aureus, and dual-species biofilms and reduced their main virulence attributes, such as the cell surface hydrophobicity of UPEC and hemolysis of S. aureus and dual-species biofilms. Gene expression studies showed ATO NPs downregulated the hla gene in S. aureus, which is essential for hemolysin production and biofilm formation. Furthermore, toxicity assays with seed germination and Caenorhabditis elegans models confirmed the non-toxic nature of ATO NPs. These results suggest that ATO nanoparticles and their composites could be used to control persistent UPEC and S. aureus infections. |
format | Online Article Text |
id | pubmed-10301033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103010332023-06-29 The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus Park, Inji Jailani, Afreen Lee, Jin-Hyung Ahmed, Bilal Lee, Jintae Pharmaceutics Article Biofilms are responsible for persistent or recurring microbial infections. Polymicrobial biofilms are prevalent in environmental and medical niches. Dual-species biofilms formed by Gram-negative uropathogenic Escherichia coli (UPEC) and Gram-positive Staphylococcus aureus are commonly found in urinary tract infection sites. Metal oxide nanoparticles (NPs) are widely studied for their antimicrobial and antibiofilm properties. We hypothesized that antimony-doped tin (IV) oxide (ATO) NPs, which contain a combination of antimony (Sb) and tin (Sn) oxides, are good antimicrobial candidates due to their large surface area. Thus, we investigated the antibiofilm and antivirulence properties of ATO NPs against single- and dual-species biofilms formed by UPEC and S. aureus. ATO NPs at 1 mg/mL significantly inhibited biofilm formation by UPEC, S. aureus, and dual-species biofilms and reduced their main virulence attributes, such as the cell surface hydrophobicity of UPEC and hemolysis of S. aureus and dual-species biofilms. Gene expression studies showed ATO NPs downregulated the hla gene in S. aureus, which is essential for hemolysin production and biofilm formation. Furthermore, toxicity assays with seed germination and Caenorhabditis elegans models confirmed the non-toxic nature of ATO NPs. These results suggest that ATO nanoparticles and their composites could be used to control persistent UPEC and S. aureus infections. MDPI 2023-06-08 /pmc/articles/PMC10301033/ /pubmed/37376127 http://dx.doi.org/10.3390/pharmaceutics15061679 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Park, Inji Jailani, Afreen Lee, Jin-Hyung Ahmed, Bilal Lee, Jintae The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus |
title | The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus |
title_full | The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus |
title_fullStr | The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus |
title_full_unstemmed | The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus |
title_short | The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus |
title_sort | antibiofilm effects of antimony tin oxide nanoparticles against polymicrobial biofilms of uropathogenic escherichia coli and staphylococcus aureus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301033/ https://www.ncbi.nlm.nih.gov/pubmed/37376127 http://dx.doi.org/10.3390/pharmaceutics15061679 |
work_keys_str_mv | AT parkinji theantibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus AT jailaniafreen theantibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus AT leejinhyung theantibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus AT ahmedbilal theantibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus AT leejintae theantibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus AT parkinji antibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus AT jailaniafreen antibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus AT leejinhyung antibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus AT ahmedbilal antibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus AT leejintae antibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus |